SCHEMBL6166926

SCHEMBL6166926

COC(=O)Oc1cc([N+](=O)[O-])nn1Cc1ccc(OC)cc1

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.52
POLB P06746 2/20 0.52
HTT P42858 2/20 0.52
CYP1A2 P05177 1/20 0.47
GAA P10253 1/20 0.46
MAPT P10636 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
HPGD P15428 1/20 0.45
RAB9A P51151 2/20 0.41
NPC1 O15118 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
KDM4E B2RXH2 1/20 0.41
LMNA P02545 1/20 0.41
MAPK1 P28482 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27878889 0.90 ALDH1A1 (0.50) ALDH1A1POLBHTTCYP1A2GAA
SCHEMBL6169286 0.90 ALDH1A1 (0.50) ALDH1A1POLBHTTCYP1A2GAA
SCHEMBL6168133 0.82 ALDH1A1 (0.41) ALDH1A1POLBHTTCYP1A2GAA
SCHEMBL1576768 0.81 ALDH1A1 (0.53) ALDH1A1POLBHTTCYP1A2GAA
SCHEMBL6169282 0.80 ALDH1A1 (0.52) ALDH1A1POLBHTTCYP1A2GAA
SCHEMBL21245001 0.79 ALDH1A1 (0.64) ALDH1A1POLBHTTCYP1A2GAA
SCHEMBL26104511 0.79 ALDH1A1 (0.50) ALDH1A1POLBHTTCYP1A2GAA
SCHEMBL26103485 0.76 ALDH1A1 (0.48) ALDH1A1POLBHTTCYP1A2GAA
SCHEMBL26102819 0.75 ALDH1A1 (0.45) ALDH1A1POLBHTTCYP1A2GAA
SCHEMBL13387618 0.74 MAPT (0.47) ALDH1A1POLBHTTCYP1A2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1503990-A1 ACTIVE SUBSTANCES FOR THE TREATMENT, DIAGNOSIS AND PROPHYLAXIS OF DISEASES IN WHICH ABNORMAL PROTEIN STRUCTURES OCCUR Transmit Gesellschaft für Technologietransfer mbH (DE) 2005-02-09 EP disclosed
WO-2003095429-A1 ACTIVE SUBSTANCES FOR THE TREATMENT, DIAGNOSIS AND PROPHYLAXIS OF DISEASES IN WHICH ABNORMAL PROTEIN STRUCTURES OCCUR TransMIT Gesellschaft für Technologietransfer mbH (DE) 2003-11-20 WO disclosed